Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene
If this proposed acquisition was a game show, it would be called "The Price Isn't Right."
These plans are more geared towards making budgetary numbers add up than fundamental welfare reform. from BBC News https://ift.tt/KvsI9qx ...
0 comments:
Post a Comment